Clinical Trials | Medications
- №391 в категории «Здоровье»
- №5 214 среди международных каналов
- №7 819 среди каналов на языке «английский»
- №8 796 в мире
Clinical Trials / Medications
- 24 часа
- 0
- 7 дней
- –
- 30 дней
- +21
- Реакции
- 0
- Репосты
- –
- Комментарии
- –
Динамика подписчиков
Подписчиков у канала «Clinical Trials | Medications»: 1 025. Прирост за последние 30 дней: 21 (2,1 %). Средний охват поста за сутки около 21, вовлечённость 2 %.
По дням, последние 30 дней
| Дата | Подписчики | Изменение | Посты | Ср. просмотры поста |
|---|---|---|---|---|
| 12 ноя | 1 025 | 0 | 0 | – |
| 11 ноя | 1 025 | +1 | 7 | 10 |
| 10 ноя | 1 024 | +1 | 5 | 22 |
| 9 ноя | 1 023 | +1 | 5 | 26 |
| 6 ноя | 1 022 | +18 | 4 | 31 |
| 7 окт | 1 004 | – | 0 | – |
Просмотры по возрасту поста
Средние просмотры в каждом возрасте, посты за последние 30 дней.
- 3 ч
- 7
- 6 ч
- 8
- 12 ч
- 13
- 24 ч
- 21
- 48 ч
- 25
- 3 дня
- 29
- 7 дней
- 29
Когда публикует
Время по UTC. 37 постов за 90 дней.
Последние посты
-
More than a warning sign: Common cardiovascular biomarker may contribute to disease Heart disease is the leading cause of death in the United States, claiming a life nearly every 34 seconds. A major driver of these fatalities is heart failure, a progressive condition where the heart struggles to pump enough blood throughout the body. https://medicalxpress.com/news/2026-11-common-cardiovascular-biomarker-contribute-disease.html
13 просмотров -
One day in the ICU without care from a pharmacist increases risk of death by 20% Patients in intensive care units who don't receive care from a pharmacist for even one day of their stay are 20% more likely to die, according to new research led by the University of Georgia. The work is published in the journal CHEST. https://medicalxpress.com/news/2026-11-day-icu-pharmacist-death.html
10 просмотров -
Could your genes affect your medications? New study highlights high probability Everyone in a diverse, nearly 100,000-person sample carried at least one genetic variant that affects how their body processes medications, and a quarter of those people had been prescribed a medication that is known to be impacted by the variant they carried, a new University of Pittsburgh–led analysis reveals in Science Translational Medicine. https://medicalxpress.com/news/2026-11-genes-affect-medications-highlights-high.html
9 просмотров -
First atlas tracks proteins that cross the blood-brain barrier Your brain is protected by the blood-brain barrier—a network of cells in the brain's blood vessels that serves as a border between the brain and the rest of your bloodstream. But it's not just a barrier; it's a sophisticated interface that shuttles specific molecules between the blood and the brain to keep your brain healthy. https://medicalxpress.com/news/2026-11-atlas-tracks-proteins-blood-brain.html
9 просмотров -
Receptor map uncovers hidden sites that could guide asthma drug design Researchers at the Center for Genomic Regulation (CRG) have developed a new way of identifying new druggable sites on a family of proteins that could help design treatments with fewer side effects for a very wide range of conditions from heart disease to depression. https://medicalxpress.com/news/2026-11-receptor-uncovers-hidden-sites-asthma.html
10 просмотров -
Molecular brace traps two cancer-driving proteins to suppress prostate cancer growth in preclinical tests Many modern cancer drugs typically target a specific protein or signaling pathway to treat tumors. Now, researchers at the University of Michigan Health Rogel Cancer Center are taking a new approach by throwing a molecular wrench into the machinery driving prostate cancer. In preclinical studies, this new approach demonstrated greater antitumor activity while sparing normal cells. https://medicalxpress.com/news/2026-11-molecular-brace-cancer-proteins-suppress.html
9 просмотров -
Effective obesity treatments reach few eligible teens, study finds Despite the arrival of powerful new anti-obesity medications and growing evidence supporting weight-loss surgery for adolescents, the vast majority of eligible teens are receiving neither treatment, according to a new study from Ann & Robert H. Lurie Children's Hospital of Chicago published in JAMA Pediatrics. https://medicalxpress.com/news/2026-11-effective-obesity-treatments-eligible-teens.html
16 просмотров -
Study identifies antidepressants that get patients well and keep them well Worldwide, nearly 6% of people experience depression. Many of them continue taking antidepressants after achieving symptomatic improvement, among other reasons to prevent a relapse of depression. An international team of researchers investigated which antidepressants, if any, can not only get patients well but also keep them well (sustained response). https://medicalxpress.com/news/2026-11-antidepressants-patients.html
21 просмотров -
Resistance training key to maintaining muscle function during GLP-1 weight loss, study shows A study has revealed that resistance (weight) training not only preserves lean and muscle mass but also increases strength in people taking weight-loss medication. Published in Nature Medicine, the Tirzepatide and Resistance Exercise (T-REx) study is the first to show the effects of combining a GLP-1 medicine and resistance training on body composition, muscle mass, strength and a range of cardiovascular health measures. https://medicalxpress.com/news/2026-11-resistance-key-muscle-function-glp.html
22 просмотров -
Blood pressure meds may improve therapy for ulcerative colitis A class of blood pressure medications may improve a widely used treatment for ulcerative colitis, the most common type of inflammatory bowel disease, suggests a new study, led by Northwestern Medicine and Kiel University in Germany, of thousands of patients with the disease. https://medicalxpress.com/news/2026-11-blood-pressure-meds-therapy-ulcerative.html
22 просмотров
-
Stronger cholesterol treatment shrinks more plaque in heart arteries, new clinical trial finds Atherosclerosis is a condition in which cholesterol and fat gradually accumulate inside the walls of medium and large arteries, forming a sticky deposit called plaque. As these deposits grow, they narrow the arteries, restricting the flow of oxygen-rich blood to vital tissues and organs. Over time, this buildup can lead to ischemic heart disease (IHD) or stroke. In a recent randomized clinical trial called FLOWPROMOTE, researchers present a strategy to reverse atherosclerosis partially. https://medicalxpress.com/news/2026-11-stronger-cholesterol-treatment-plaque-heart.html
39 просмотров -
Fatty acid metabolism may help eliminate damaged and senescent cells Researchers have identified a mechanism involving fatty acid metabolism that may determine whether a damaged cell enters senescence and persists in the body or is eliminated through cell death. Published in the journal Cell, the study could open new avenues for treating age-related diseases. Researchers from the University of Eastern Finland contributed to the international study. https://medicalxpress.com/news/2026-11-fatty-acid-metabolism-senescent-cells.html
39 просмотров -
Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials For people with painful knee osteoarthritis (OA) who are overweight or have obesity, everyday activities such as walking, climbing stairs and standing up from a chair can be difficult. In two Northwestern University–led Phase III clinical trials involving more than 1,000 participants combined, those taking the highest dose of retatrutide, a new experimental weight-loss injectable drug, lost about one-quarter of their body weight on average. https://medicalxpress.com/news/2026-11-experimental-weight-loss-drug-eases.html
37 просмотров -
Scientists use AI to develop bird flu vaccine that outperforms current stockpiled shot A University of Cambridge team has had a third success with its AI-guided technique for designing vaccines against highly infectious viruses that threaten animal and human health. Its new broad-spectrum bird flu vaccine gave complete protection against globally circulating, diverse variants of the disease in animal trials. https://medicalxpress.com/news/2026-11-scientists-ai-bird-flu-vaccine.html
36 просмотров -
Heart researchers unpack neutral findings from ZEUS, an anti-inflammatory clinical trial Like cholesterol, inflammation causally contributes to the risk of cardiovascular disease, but findings from the clinical trial ZEUS indicate that the road to targeting inflammation may be less straightforward than once thought. ZEUS, a global phase 3 clinical trial led by Mass General Brigham researcher Paul Ridker, M.D., tested a drug that targets interleukin-6 (IL-6), a downstream inflammatory molecule. IL-6 inhibitors are commonly used to treat autoimmune disorders. However, while the new drug known as ziltivekimab lowered IL-6 levels, it did not reduce cardiovascular event rates compared to placebo...
35 просмотров -
Advanced imaging uncovers genomic Achilles' heel that makes cancer cells vulnerable A small subset of vulnerable DNA sites can make cancer cells highly sensitive to targeted drugs called PARP inhibitors, a new study shows. Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the work revolved around failures of DNA to copy itself at certain sites in genetic chains, which it must do for cells to divide and multiply as part of healing and growth. Cancerous cells depend on protective mechanisms that have evolved to overcome these failures when they are triggered by cancer drugs. https://medicalxpress.com/news/2026-11-advanced-imaging-uncovers-genomic-achilles.html
35 просмотров -
About half of drinkers on GLP-1s say they imbibed less Nearly half of drinkers who take GLP-1 medications have reported declines in consumption, with the effect higher among those at risk of unhealthy alcohol use, a new Harvard study shows. The work, published in the journal JAMA Psychiatry, explores an unexpected side effect of GLP-1s used to treat diabetes and obesity. https://medicalxpress.com/news/2026-11-drinkers-glp-1s-imbibed.html
34 просмотров -
New study challenges belief that women are more sensitive to the effects of cannabis Men who use cannabis occasionally reacted more strongly to smoked cannabis than women with similar use habits, even though the amount of THC in their blood was about the same, according to a new study from UCLA Health. The findings run counter to earlier research suggesting that women are more sensitive to cannabis. https://medicalxpress.com/news/2026-11-belief-women-sensitive-effects-cannabis.html
34 просмотров -
Crigler-Najjar syndrome: Gene therapy maintains its efficacy four years after treatment The New England Journal of Medicine has published a study on the long-term efficacy of AAV8-mediated gene therapy (GNT0003) in patients with Crigler-Najjar syndrome, an extremely rare congenital liver disorder affecting approximately 500 people in Europe. It is caused by a deficiency of UGT1A1, an enzyme required for bilirubin metabolism. The accumulation of this substance can lead to irreversible neurological damage and, in the most severe cases, death. https://medicalxpress.com/news/2026-11-crigler-najjar-syndrome-gene-therapy.html
31 просмотров -
Mindfulness therapy assisted by ketamine may strengthen body awareness to reduce opioid cravings Researchers from the University of California San Diego School of Medicine have found that adding ketamine to a mindfulness-based treatment for opioid use disorder may strengthen people's ability to recognize and respond to signals from their bodies—changes that may help reduce opioid cravings. The study, published on Nov. 5, 2026, in the Journal of Psychopharmacology, provides new insight into how ketamine-assisted psychotherapy may enhance addiction treatment. https://medicalxpress.com/news/2026-11-mindfulness-therapy-ketamine-body-awareness.html
31 просмотров
Вопросы о канале «Clinical Trials | Medications»
Сколько подписчиков у канала «Clinical Trials | Medications»?
У канала «Clinical Trials | Medications» (@clinical_trials) 1 025 подписчиков на 12 ноября 2026 г.
Растёт ли канал «Clinical Trials | Medications»?
Да. Прирост за последние 30 дней: 21 (2,1 %).
Сколько человек видят пост в канале «Clinical Trials | Medications»?
Средний пост набирает около 21 просмотров за 24 часа, это примерно 2 % подписчиков (ERR).
О чём канал «Clinical Trials | Medications»?
Канал в категории «Здоровье», язык постов: английский. Описание канала: «Clinical Trials / Medications»
Какое место занимает канал «Clinical Trials | Medications»?
По числу подписчиков: №391 в категории «Здоровье», №5 214 среди международных каналов, №7 819 среди каналов на языке «английский», №8 796 в мире.
Публикует ли канал «Clinical Trials | Medications» рекламу?
За последние 30 дней ни один из 37 постов не помечен как реклама (#ad, Sponsored, «Реклама»). Рекламу без пометки определить нельзя.
Статистика обновлена 1 час назад.